Global Monoclonal Antibodies Market (2020 to 2030) - by Source, Category, Production Type, Application, End User and Region
25 janv. 2022 05h43 HE
|
Research and Markets
Dublin, Jan. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibodies Market 2020-2030 by Source, Category, Production Type, Application, End User, and Region: Trend Forecast and Growth...
Worldwide Filgrastim Industry to 2027 - An Increase in the Aging Population is Driving Growth
21 janv. 2022 04h29 HE
|
Research and Markets
Dublin, Jan. 21, 2022 (GLOBE NEWSWIRE) -- The "Global Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027"...
Asia Pacific Biologics Contract Manufacturing Industry to 2031 - Featuring Fujifilm Holding, AbbVie and Boehringer Ingelheim Among Others
18 janv. 2022 06h53 HE
|
Research and Markets
Dublin, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The "Biologics Contract Manufacturing Market - Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added...
Arthritis Monoclonal Antibodies Global Market Report 2021-2030: COVID-19 Growth and Change
18 janv. 2022 04h38 HE
|
Research and Markets
Dublin, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The "Arthritis Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
Global Next-Generation Biomanufacturing Market Report 2021-2031: Growing Trend among Biomanufacturing Vendors to Integrate Automation Technologies
14 janv. 2022 04h43 HE
|
Research and Markets
Dublin, Jan. 14, 2022 (GLOBE NEWSWIRE) -- The "Next-Generation Biomanufacturing Market - A Global Analysis: Focus on Single-Use and Digital Platform and Segment Analysis for Workflow, Products,...
Vir Biotechnology Launches New Antibody Research Initiative Aimed at a Functional Cure for HIV and Prevention of Malaria
13 janv. 2022 09h05 HE
|
Vir Biotechnology, Inc.
– New commitment from the Bill & Melinda Gates Foundation supports the development of Vir’s novel “vaccinal antibody” technology as another important step in the fight to address global...
GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19
13 janv. 2022 09h02 HE
|
Vir Biotechnology, Inc.
– If authorized, would provide the option for intramuscular administration of sotrovimab, in addition to currently authorized intravenous administration – – Submission follows COMET-TAIL Phase 3...
GSK and Vir Biotechnology Announce United States Government Agreement to Purchase Additional Supply of Sotrovimab, Authorized for the Early Treatment of COVID-19
11 janv. 2022 07h12 HE
|
Vir Biotechnology, Inc.
– 600,000 additional doses to be supplied to the US government for distribution in Q1 2022, enabling further access to sotrovimab nationwide – – Brings total number of doses secured to date through...
Regulatory T-Cell Therapies Market, 2035
11 janv. 2022 04h58 HE
|
Research and Markets
Dublin, Jan. 11, 2022 (GLOBE NEWSWIRE) -- The "Regulatory T-Cell Therapies Market by Target Indications, Key Players and Key Geographies: Industry Trends and Global Forecast, 2021-2035" report has...
Global $49.77 Cancer Monoclonal Antibodies Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F
10 janv. 2022 05h18 HE
|
Research and Markets
Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering....